Back to EZorb Newsletter Index

 

EZorb

 

EZORB MONTHLY NEWSLETTER JAN 28, 2008

In this issue:

1. Share Success: Letters From Readers
2.

News: FDA Warns of Severe Pain with Osteoporosis Drugs

3. Useful Links
4. Calcium Absorption Test
5. What Are Others Saying About EZorb?
 

 

1. Share Success: Letters From Readers 

***************************************************

Letter I: From Bonnie G.

Received at ezorb @ ezorbonline.com on Sun, 13 Jan 2008 15:23:16 -0600

(Unedited)

 

Thank you for responding so quickly. I received the result of by bone density yesterday and I am so thrilled to tell you that the results are "normal". This is astounding since I was at the bottom of the red zone and the doctor was talking about infusions for three years before I even had the test done. I know the doctor must find this hard to believe.

 

I am so grateful and thankful that I found EZorb on the web. Two other people that I told about EZorb, started to use it and are waiting to hear about my results. I know they will be astounded too.

 

Thanks again, 

Bonnie G.

 

Letter II: From Dawn B.

Received at Testimonial Submit Form on Sunday, December 16, 2007 at 02:07:23

(Unedited)

 

Dear Elixir Industry,

 

I found your EZorb product while searching for a heel spur remedy on the internet. I have now taken the EZorb powder for four months and I am thrilled with the results! Not only has my heel spur disappeared, but my bone and joint pain has decreased tremendously as well. My nails have become so strong and don't break and my hair is no longer falling out.

 

My life has changed so much. I told four of my dear friends who have all placed orders for the EZorb and the MARVLIX. Now they are just as devoted and thrilled as I am.

 

Last month I ordered my first bottle of MARVLIX. I noticed that I feel calmer and less stressed after only two weeks!

 

Your products are amazing and they really work! I can't believe that I was looking for a heel spur remedy and found the "fountain of youth".

 

Thank you so very, very much for changing my life by offering such beneficial products. You are a God send.

 

Dawn B.

Age 59

 

Letter III: From Wayne Cross

Received at Testimonial Submit Form on Friday, Friday, October 19, 2007 at 17:52:12

(Unedited)

 

I want to thank you so much for your product of calcium aspartate anhydrous. I had bone spurs and in three week there is a dramatic change I can walk without pain and I did not need an operation or special shoes. This medicine is wonderful and anyone suffering with bone spurs at least try it you have nothing to lose and everything to gain and be like me. The price is high but an operation is a lot higher and so are the shoes, again please try this, I'm glad I did.

 

I'll recommend this very highly. Please feel free to use my name.

 

Wayne

***************************************************

From the Desk of EZorb Newsletter Editor:

This newsletter is now read by over 50,000 subscribers worldwide. Success stories you contribute will have great impact on many people's life. Kindly email your story to sharesuccess @ ezorbonline.com. As always your private information will never be revealed to the public.

 

2. News: FDA Warns of Severe Pain with Osteoporosis Drugs

 

By Lisa Richwine

 

WASHINGTON (Reuters) - Patients treated with widely used osteoporosis drugs may develop severe and sometimes disabling pain in muscles, joints and bones, U.S. officials said on Monday in an alert highlighting the previously known risk.

 

The warning applies to Merck & Co Inc's Fosamax, Roche Holding AG and GlaxoSmithKline PLC's Boniva, plus all other members of the family known as bisphosphonates.

 

The risk of severe pain with the drugs has been known for years, but health officials said doctors may be overlooking the medicines as a cause.

 

Doctors "should consider whether bisphosphonate use might be responsible for severe musculoskeletal pain ... and consider temporary or permanent discontinuation of the drug," the Food and Drug Administration said in an alert posted on its Web site.

The prescribing instructions for the drugs already mention the risk of severe pain in a list of "precautions" for doctors. Manufacturers said cases of incapacitating pain were uncommon.

 

The muscle, joint or bone pain "may occur within days, months or years after starting a bisphosphonate," the FDA said.

Some patients reported the pain was so severe it interfered with normal activities and they required aids for walking.

In some cases, pain disappeared after stopping a bisphosphonate, "whereas others have reported slow or incomplete resolution," the FDA said.

 

FDA spokeswoman Susan Cruzan said the agency is reviewing hundreds of reports of pain in bisphosphonate users, noting that prescriptions for the drugs number in the millions. Potential side effects typically are under-reported, she added.

 

The ongoing FDA review will take about six months, the agency said.

Bisphosphonates are used primarily to increase bone mass and reduce the risk of fractures in patients with osteoporosis, which weakens bones and increases the risk of fractures. Some of the drugs are injected and some are oral pills.

 

The other bisphosphonates include Actonel, sold by Procter & Gamble and Sanofi-Aventis; Novartis AG's Zometa, Aredia and Reclast; P&G's Didronel; and Sanofi's Skelid. Reclast is sold outside the United States as Aclasta.

 

Novartis said reports of severe pain were rare among bisphosphonate users. Clinical trials and post-approval reporting for Reclast/Aclasta and Zometa showed less than 1 percent of patients experienced incapacitating muscle, joint or bone pain, the company said in a statement.

 

Roche and Procter & Gamble said reports of disabling pain were "infrequent".

 

Merck said its instructions for Fosamax tell doctors to stop prescribing the drug if severe pain develops. "Most patients had relief of symptoms after stopping treatment," the company said.

The pain is different from acute pain that some patients develop with fever, chills and other symptoms soon after starting the drugs, the FDA said. That type of pain usually resolves within several days while drug treatment continues.

 

In October, the FDA disclosed a separate review of whether bisphosphonates may be linked to a dangerously fast heartbeat known as atrial fibrillation. That review could take as long as a year, the agency said at the time.

 

The new FDA alert was posted at: www.fda.gov/cder/drug/InfoSheets/HCP/bisphosphonatesHCP.htm 

 

3. Useful Links

Frequently Asked Questions & Answers

EZorb Clinical Studies

Marvlix Benefits

Order Now

 

4. Calcium Absorption Test

EZorb Calcium has set a new world record of absorption rate. You can compare EZorb with other calcium supplements by using the simple step-by-step instructions we provide. E-mail your request to test @ ezorbonline.com for a copy of the instructions.

 

5. What Are Others Saying About EZorb?

EZorb Calcium has restored confidence in thousands of men and women. It has brought happiness and healthy life to families around the world. Click here to read what people say about EZorb.

  

Back to EZorb Newsletter Index

 
 
  Copyright 2008 Elixir Industry